54 results on '"Currier, Judith S"'
Search Results
2. Trans women have worse cardiovascular biomarker profiles than cisgender men independent of hormone use and HIV serostatus
3. Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection
4. Grayscale Ultrasound Texture Features of Carotid and Brachial Arteries in People With HIV Infection Before and After Antiretroviral Therapy
5. Machine Learning Algorithms Using Routinely Collected Data Do Not Adequately Predict Viremia to Inform Targeted Services in Postpartum Women Living With HIV
6. Poorer Muscle Quality and Quantity With ART Initiation Is Associated With Greater Inflammation and Immune Activation
7. Effects of HIV Infection on Arterial Endothelial Function
8. Maternal HBV Viremia and Association With Adverse Infant Outcomes in Women Living With HIV and HBV
9. Comparison of guidelines for HIV viral load monitoring among pregnant and breastfeeding women in sub-Saharan Africa
10. Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared with men
11. Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women
12. Brachial Artery Echogenicity and Grayscale Texture Changes in HIV-Infected Individuals Receiving Low-Dose Methotrexate
13. Birth Outcomes for Pregnant Women With HIV Using Tenofovir-Emtricitabine
14. Brief Report: Changes in Plasma RANKL-Osteoprotegerin in a Prospective, Randomized Clinical Trial of Initial Antiviral Therapy: A5260s
15. Soluble levels of receptor for advanced glycation endproducts and dysfunctional high-density lipoprotein in persons infected with human immunodeficiency virus
16. Antiretroviral initiation is associated with increased skeletal muscle area and fat content
17. Predictors of Impaired HDL Function in HIV-1 Infected Compared to Uninfected Individuals
18. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
19. Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection
20. Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery
21. A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness
22. Comparison of HBV-active HAART regimens in an HIV–HBV multinational cohort
23. Proteinuria is Associated With Neurocognitive Impairment in Antiretroviral Therapy Treated HIV-Infected Individuals
24. Biomarkers From Late Pregnancy to 6 Weeks Postpartum in HIV-Infected Women Who Continue Versus Discontinue Antiretroviral Therapy After Delivery
25. Body Composition, Soluble Markers of Inflammation, and Bone Mineral Density in Antiretroviral Therapy–Naive HIV-1–Infected Individuals
26. Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection
27. Characterization of HIV–HBV coinfection in a multinational HIV-infected cohort
28. Abstract 262: HIV-1--Infected Subjects with Low Viremia Have Dysfunctional HDL Compared with Healthy Subjects
29. Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women
30. Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229
31. Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima–media thickness
32. Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study
33. Safety and Efficacy of Initiating Highly Active Antiretroviral Therapy in an Integrated Antenatal and HIV Clinic in Johannesburg, South Africa
34. Abstract 1248.5: Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Class-Sparing Antiretroviral Therapy: ACTG Study A5152s
35. State of the Science Conference
36. Guidelines for managing cardiovascular risk: an evolving area
37. Progression of carotid artery intima–media thickening in HIV-infected and uninfected adults
38. Response to: ‘Carotid intima-media thickness: assessment of sub-clinical atherosclerosis in HIV-infected patients’
39. Carotid artery intima–media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure
40. Coronary Heart Disease in HIV-Infected Individuals
41. Management of Metabolic Complications Associated With Antiretroviral Therapy for HIV-1 Infection: Recommendations of an International AIDS Society–USA Panel
42. Introduction
43. Cardiovascular Risk Associated With HIV Therapy
44. A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 × 106/l
45. Differences Between Women and Men in Adverse Events and CD4+ Responses to Nucleoside Analogue Therapy for HIV Infection
46. Differences Between Women and Men in Adverse Events and CD4+ Responses to Nucleoside Analogue Therapy for HIV Infection
47. Absence of virological changes after acute febrile illnesses in two patients with undetectable pre-illness plasma HIV-1-RNA levels
48. Predictive Markers of HIV-Related Weight Loss and Determination of Differences Between Populations With Weight Loss Stratified by Opportunistic Processes
49. Predictive Markers of HIV-Related Weight Loss and Determination of Differences Between Populations With Weight Loss Stratified by Opportunistic Processes
50. Joint effects of HIV-1 RNA levels and CD4 lymphocyte cells on the risk of specific opportunistic infections
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.